Mydecine Innovations Group Inc.
MYCOF
$0.0065
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 125.30K | -1.82M | -2.36M | -9.15M | -8.57M |
| Total Depreciation and Amortization | -- | -- | -- | 0.00 | 900.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.90K | 537.50K | 557.70K | 3.98M | 3.88M |
| Change in Net Operating Assets | -137.30K | 1.27M | 1.77M | 4.91M | 4.38M |
| Cash from Operations | -9.00K | -9.20K | -28.60K | -259.70K | -311.80K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Investing | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | 110.00K | 110.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 283.00K | 284.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | 288.90K | 289.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.00K | -9.20K | -28.60K | 29.10K | -22.20K |